1. Home
  2. DSS vs BIAF Comparison

DSS vs BIAF Comparison

Compare DSS & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSS

DSS Inc.

HOLD

Current Price

$0.49

Market Cap

5.3M

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.67

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSS
BIAF
Founded
1984
2014
Country
United States
United States
Employees
N/A
57
Industry
Containers/Packaging
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
4.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DSS
BIAF
Price
$0.49
$1.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.5K
179.3K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
42.45
N/A
EPS
N/A
N/A
Revenue
$2,085,000.00
N/A
Revenue This Year
$1.21
$20.95
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.23
52 Week High
$1.90
$13.50

Technical Indicators

Market Signals
Indicator
DSS
BIAF
Relative Strength Index (RSI) 41.31 38.53
Support Level N/A $1.26
Resistance Level $1.04 $1.79
Average True Range (ATR) 0.04 0.18
MACD 0.01 0.03
Stochastic Oscillator 61.06 36.13

Price Performance

Historical Comparison
DSS
BIAF

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: